Abstract
Mylan Pharms. Inc. v. Merck Sharp & Dohme Corp. <i>United States Court of Appeals of the Federal Circuit, 2022 50 F.4th 147</i>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1089/blr.2022.29290.cip
Copy DOIJournal: Biotechnology Law Report | Publication Date: Dec 1, 2022 |
Mylan Pharms. Inc. v. Merck Sharp & Dohme Corp. <i>United States Court of Appeals of the Federal Circuit, 2022 50 F.4th 147</i>
Join us for a 30 min session where you can share your feedback and ask us any queries you have